Semalytix

About Semalytix

Semalytix operates in the pharmaceutical and healthcare market, providing AI-driven solutions to understand patient needs and optimize clinical trials. The company's core product, Pharos Suite, leverages artificial intelligence to analyze millions of online patient experience data points, generating insightful monthly executive reports. These reports help pharmaceutical companies measure unmet needs, quality of life burdens, and treatment experiences, thereby accelerating evidence generation by 50%. Semalytix serves pharmaceutical companies and healthcare providers, offering them a comprehensive understanding of patient experiences and needs. The business model is based on subscription services for its AI-powered reports and insights. Revenue is generated through these subscriptions, providing clients with unlimited market research insights on thousands of patients. The company operates globally, tapping into 50 million real-world patient experience data points to deliver valuable insights.